Cardiff Lexington Corporation (CDIX) Fair Value 2026

CDIX · Medical Care Facilities ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

5.7 /10

32 fundamental signals · 2 models active

Value Trap Risk

WARN (49/100)

Quick Summary — As of 2026-08-27, Cardiff Lexington Corporation (CDIX) trades at $0.25, versus a $0.82 median fair value across its 2 active models — 228.7% above the current price. QOC: 5.7/10. Value Trap Risk: 49/100 (WARN). 2/13 models active.

Key Facts

Ticker
CDIX
Price
$0.25
Quality Score
5.7/10
Value Trap Risk
49/100
Models Active
2/13
Last Updated
Strength: PWERM suggests +288.5% upside with 40% confidence
Risk: Value Trap score of 49 suggests caution despite apparent undervaluation

Is Cardiff Lexington Corporation (CDIX) Undervalued or Overvalued in 2026?

According to CirclFi’s 2-model valuation engine, Cardiff Lexington Corporation (CDIX) appears undervalued as of : the median of 2 independent fair value estimates is $0.82, 228.7% above the current price of $0.25. Estimates range from $0.67 to $0.97. CDIX scores 5.7/10 on fundamental quality and 49/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.7% versus its own 13-model consensus, across 3,801 rated companies as of 2026-08-27. CDIX’s +228.7% gap is wider than that market norm, and the Medical Care Facilities sector median is -28.6%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Cardiff Lexington Corporation Stock in 2026? →

What Fair Value Does Each Model Give CDIX?

2 Intrinsic Value Models vs. Current Price ($0.25)

Core Models (Unlocked)
Model Fair Value Upside
Scenario · High Conviction
 $0.67 +169.0%
Option-Based · Medium Conviction
 $0.97 +288.5%

All Models Active

All 2 models are displayed above.

What Is Cardiff Lexington Corporation (CDIX) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Cardiff Lexington Corporation is potentially undervalued at its current price of $0.25. Based on our 13-model framework, Cardiff Lexington Corporation's intrinsic value is estimated at a median fair value of $0.82 — representing +228.7% implied upside — with 2 out of 2 active models confirming this thesis. Model dispersion is worth noting: PWERM targets $0.97 (+288.5%), versus First Chicago at $0.67 (+169.0%). This +119.4% range highlights the importance of multi-model analysis rather than relying on any single methodology.

What Do the Models Say About CDIX?

2 of 13 models are currently active for CDIX. All 2 active models suggest the stock trades below fair value. Taken together, their median fair value for CDIX is $0.82 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does CDIX Rank in Medical Care Facilities?

Among 60 Medical Care Facilities stocks, CDIX ranks #44 by Quality of Company score. CirclFi's QOC score of 5.7/10 evaluates 32 fundamental signals. A score of 5.7 reflects mixed fundamentals.

See all Most Undervalued Medical Care Facilities Stocks →

Cardiff Lexington Corporation operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is CDIX a Value Trap?

CirclFi's Value Trap algorithm assigns CDIX a score of 49/100 (WARN). This is a warning signal. Additional research into recent 10-Q filings is recommended. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

2 of 13 models are active for Cardiff Lexington Corporation. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, Cardiff Lexington Corporation earns a quality score of 5.7/10. This respectable rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency. Our Value Trap detector shows moderate caution signals worth monitoring.

The gap between the most bullish and bearish model spans +119.4% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every CDIX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across CDIX's 2 active models, average confidence is 48%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Cardiff Lexington Corporation Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Care Facilities Stocks Should You Also Analyze?

11 related Medical Care Facilities stocks with 13-model coverage

BKDBrookdale Senior Living Inc.QOC 5.7STLNThe Oncology Institute, Inc.QOC 5.6EHSIElite Health Systems Inc.QOC 5.8ACHCAcadia Healthcare Company, Inc.QOC 5.6AMSAmerican Shared Hospital ServicesQOC 5.9WWWW International, Inc.QOC 5.5XCRTXcelerate Inc.QOC 3.2MDPediatrix Medical Group, Inc.QOC 7.9INNVInnovAge Holding Corp.QOC 6.7ADUSAddus HomeCare CorporationQOC 8.9NHCNational HealthCare CorporationQOC 8.7

Read investment analysis: BKD · STLN · EHSI · ACHC · AMS · WW · XCRT · MD · INNV · ADUS · NHC

Which Other Stocks Have a Similar Quality Score to CDIX?

7 companies across all industries closest to CDIX’s Quality of Company score of 5.7/10.

MGNCMag Magna Corp.QOC 5.7SEATVivid Seats Inc.QOC 5.6IVAInventiva S.A.QOC 5.7PREPrenetics Global LimitedQOC 5.6PEDPEDEVCO Corp.QOC 5.7ACDCProFrac Holding Corp.QOC 5.6NVDANVIDIA CorporationQOC 10.0

Read investment analysis: MGNC · SEAT · IVA · PRE · PED · ACDC · NVDA

Where Does CDIX Sit in CirclFi's Medical Care Facilities Rankings?

CDIX is ranked against every other Medical Care Facilities stock CirclFi covers in each of these screens.

See all Medical Care Facilities stocks ranked →

What Else Do Investors Ask About Cardiff Lexington Corporation’s Valuation?

What is Cardiff Lexington Corporation's intrinsic value in 2026?

CirclFi puts Cardiff Lexington Corporation (CDIX)'s intrinsic value at $0.82 — the median of 2 independent model estimates as of 2026-08-27, ranging from $0.67 to $0.97. The Quality of Company score is 5.7/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is CDIX overvalued or undervalued right now?

At $0.25, 2 of 2 active models suggest CDIX may be undervalued, while 0 indicate potential overvaluation. The median of all 2 fair value estimates is $0.82, 228.7% above the current price of $0.25 — a consensus view that CDIX is undervalued. The assessment depends on which methodology best fits Cardiff Lexington Corporation's business model in Medical Care Facilities.

What does a Quality of Company score of 5.7 mean for CDIX?

Cardiff Lexington Corporation's QOC of 5.7/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on CDIX?

CirclFi analyzes CDIX with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 2 of 13 are active for this stock. Read the full methodology →

Is CDIX a value trap in 2026?

Cardiff Lexington Corporation's Value Trap score is 49/100 (WARN). This elevated score suggests the stock may look undervalued but faces deteriorating fundamentals — declining margins, rising debt, or shrinking revenue could make the apparent discount deceptive. Browse our ranked stock lists to compare value-trap scores across industries. Browse stocks by value-trap risk →

Cite this analysis — “According to CirclFi’s 2-model valuation engine, Cardiff Lexington Corporation (CDIX) has a median fair value of $0.82 — 228.7% above the current price of $0.25 — as of 2026-08-27.” Source: circlfi.com/stock/CDIX/ · Methodology
Primary sources for this CDIX valuation
  • Financial statements: Cardiff Lexington Corporation 10-K and 10-Q filings on SEC EDGAR (CIK 0000811222) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for CDIX as of ; valuations recomputed .